Skip to main content
Blog-Banner

Modifications to Medical Device Registration in Mexico

|
  • Legal Manufacturer: Natural or legal person responsible for the safety, performance, quality, design, manufacture, conditioning or assembly of a system, or restoration, modification or adaptation of a medical device prior to its commercialization and its release as a finished product, regardless of whether these operations are carried out by the same entity or by a third party.
  • Real Manufacturer: Entity in charge of manufacturing, assembling, or remanufacturing a medical device (may be a subsidiary of the legal manufacturer), or contracted by the legal manufacturer to carry out manufacturing through a quality or contract agreement.
  • When there are changes in the pharmaceutical form or physical presentation.
  • When there is a substitution of the active ingredient or change of the material in its case.
  • When new models of Medical Devices present technological advances that modify the main purpose of use, for which it was authorized.
  • When there are changes in the components or parts of the product that affect the functionality or purpose of use thereof.
  • Any modification or change that is made to the conditions under which the health registration was approved and that changes the purpose and indication of use will require a new health registration.
  • Product Formulation Changes (in particular changes of active ingredients), physical presentation, changes of raw materials, technology advances, changes of components that have an impact on the functionality or intended purpose of the device, and changes that represent an alteration of the intended use will require a new registration.
  • The original registration route will need to be maintained through subsequent modifications, so documentation will need to be supplied consistently (i.e., a model addition modification for a Health Canada registration, will require a Health Canada license, instead of any other Certificates of Free Sale (CFS) available to the manufacturer in other markets, such as a US Food and Drug Administration (FDA)-issued Certificate to Foreign Government, or CFG)
  • It is important to ensure that the registration route selected is optimal for the device throughout its product life cycle.
  • Change of address of the local or foreign distributor.
  • Change of company name of the registration holder, manufacturer or distributor.
  • Change of distributor.
  • Change of company name of the legal manufacturer.
  • Change of company name and address of the legal manufacturer.
  • Change of commercial name or product catalog number.
  • Change of secondary packaging material.
  • Removal of sales presentations.
  • Removal of distributors and/or manufacturer.
  • Change of manufacturing sites of the national or foreign manufacturer.
  • Change of contract manufacturer.
  • Reclassification of the medical device based on the level of health risk.
  • Change of primary and secondary packaging material.
  • Change of shelf-life or Expiry Date.
  • Model additions that do not represent technological advances nor modify the main intended use.
  • Change of Formulation.
  • Change of the registration holder.
  • The guideline mentions that when the Mexico Registration Holder (MRH) is listed as importer or distributor, rights transfer modifications may also tolerate changes to the importer and distributor section of the registration, as long as this is reflected on the label design and the modification contains the necessary representation letters for the supply chain participants. This apparently confirms that distributor changes are once again accepted under rights transfer modifications.
  • Address updates resulting from street, city or zip code renaming conducted by government mandate, will require documentation issued by the authorities showing evidence that such is the case, or alternatively evidence of the notification to the notified body from the manufacturer to perform the address update on their Good Manufacturing Practice (GMP) certification.
  • Address or company name changes for the legal manufacturer will now require updated legalized representation letters issued by the manufacturer to the registration holder and distributors.
  • Legal manufacturers may be added even without a CFS (or equivalent), as long as there’s documentation evidence of the relationship between stakeholders.
  • Legal documents shall be less than 30 months old when their validity periods haven’t been specified.
  • It has been defined that whenever a CFS is a requirement, it must contain the product’s commercial name/trade name, models, list of codes and the manufacturer information.
  • All the information required on a Certificate of Analysis (when required) is clearly defined, including examples of other standard documentation that may fulfill this requirement (DHR, BPR, FIR, SFP).
  • Modifications for registrations of condoms will require certificates of analysis issued by local laboratories. Requirements for shelf-life modifications include precise details reflecting the recent updates to the Supplement.
  • Formulation changes must submit a formulation statement signed by the responsible quality representative, stability or aging studies, and Certificates of Analysis.
  • There is confirmation that e-signatures are acceptable.
Get the latest updates from Vistaar

    Subscribe

    Share the Blog:

    Previous Post

    Next Post

    CONNECT WITH US

      Subscribe